Braskem (BAK) Cash & Equivalents (2009 - 2025)

Braskem has reported Cash & Equivalents for 17 years, with the latest figure at $1.9 billion in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 24.47% year-over-year to $1.9 billion in Q4 2025; TTM through Dec 2025 was $1.9 billion, a 24.47% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 24.47% from the prior year.
• Cash & Equivalents was $1.9 billion for Q4 2025 at Braskem, up from $1.9 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $2.9 billion in Q4 2023, with the low at $1.6 billion in Q4 2021.
• Average Cash & Equivalents over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents tumbled 39.39% in 2021, then soared 52.26% in 2022.
• Over 5 years, Cash & Equivalents stood at $1.6 billion in 2021, then jumped by 52.26% to $2.4 billion in 2022, then climbed by 20.94% to $2.9 billion in 2023, then decreased by 10.02% to $2.6 billion in 2024, then slipped by 24.47% to $1.9 billion in 2025.
• The last three Cash & Equivalents figures came in at $1.9 billion (Q4 2025), $1.9 billion (Q1 2025), and $2.6 billion (Q4 2024), per Business Quant data.